VOICED : OMS homologa vacuna anticovid Covaxin, del laboratorio indio Bharat Biotech

The World Health Organization (WHO) has validated the Indian-made Covaxin vaccine, developed by Bharat Biotech, for emergency use. Covaxin shows a 78% efficacy rate and is recommended for individuals aged 18 and above. It requires two doses four weeks apart and is suitable for low-resource countries due to its easy storage requirements. This marks the first time a vaccine fully developed and manufactured in India has received WHO approval, joining other vaccines like Pfizer-BioNTech and Moderna. The approval aids in international recognition and supports global vaccination efforts, particularly in poorer countries through the Covax system.

What is the efficacy rate of the Covaxin vaccine as validated by the WHO?

• 70%

• 78%

• 90%

• 85%

For which age group is the Covaxin vaccine recommended?

• 12 years and above

• 16 years and above

• 18 years and above

• 21 years and above

How many doses of Covaxin are required for full vaccination?

• One dose

• Two doses

• Three doses

• Four doses

Which feature makes Covaxin particularly suitable for countries with limited resources?

• Fast production

• Easy storage

• Low cost

• High efficacy

Which system is designed to facilitate vaccine access in poorer countries?

• COVAX

• GAVI

• UNICEF

• WHO